Connected for impact: Nucleate & Sanofi powering Europe’s Bio Innovation
Paris is a powerhouse of scientific research, home to renowned research institutions and a global pharmaceutical center. Yet, the ecosystem is fragmented across academia, startups, pharma, and venture. Too often, these stakeholders operate in parallel rather than in true dialogue, slowing the translation of discoveries into impact. This is especially pressing in the field of AI, where Europe has strong research but has not yet fully mobilised it into innovation at scale. Without deeper collaboration, Europe risks underleveraging both its talent and its science.
This event will address these challenges by highlighting Sanofi’s commitment to open innovation and its partnership with Nucleate worldwide. We will explore how AI-driven approaches, strategic partnerships, and cross-border communities can accelerate the translation of scientific discovery into scalable biotech solutions.
Agenda:
Keynote: Jacques Volckmann - Global Head external innovation Sanofi
Keynote: Nucleating Systems of Innovation
Nucleate Activator teams showcase:
Four cutting-edge startups from Nucleate’s Activator, working at the frontier of AI x Biotech.
Panel discussion:
Jacques Volckmann : Global Head - External Innovation
Danilo Casimiro: CSO & Global Head of external scientific affairs - Vaccines
Albert Pla Planas: Digital R&D
Zhizhong Yao: Partner Sofinnova
Oliver Dodd: Executive Director Nucleate
Connect with Europe’s top talent in AI and biology, visionary founders, and industry leaders, connections that will position Paris and Sanofi at the center of AI-driven innovation.
About the Host:
Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.xyz for more information, and visit https://nucleate.xyz/privacy-policy/ to read our privacy policy.
We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!
Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma
Philanthropic Support: Lyda Hill Philanthropies
Preferred Partners: Pillar VC, Amino Collective, Excedr, Mercury, Brex, Fedsprout
In-Kind Support: AcademicLabs, Lens.org, SynBioBeta